Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

BACKGROUND: The aim of this study was to evaluate the proportion of patients with ankylosing spondylitis maintaining clinical remission after reduction of their subcutaneous etanercept dose to 50 mg every other week compared with that in patients receiving etanercept 50 mg weekly. METHODS: In the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Fabrizio, Niccoli, Laura, Cassarà, Emanuele, Kaloudi, Olga, Nannini, Carlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540908/
https://www.ncbi.nlm.nih.gov/pubmed/23319853
http://dx.doi.org/10.2147/BTT.S31474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540908/
https://www.ncbi.nlm.nih.gov/pubmed/23319853
http://dx.doi.org/10.2147/BTT.S31474

Ejemplares similares